[ad_1]
FDA secretary reveals three more COVID-19 vaccines “Moderna-Sputnik-Sino Farm” is preparing to submit a registration application, while the other two companies are in the process of submitting an ongoing document.
Today (March 25, 2021) Dr. Paisan Dankhum, Secretary General of the Food and Drug Administration (FDA) He revealed it from the Food and Drug Administration (FDA), which is in charge of registering the COVID-19 vaccine. You have facilitated AND open a special channel to submit a registration request. Being able to quickly approve the last record. Johnson & Johnson vaccine (Johnson & Johnson) By Janssen-Sealax Company Limited, which is a private sector applying for registration, it has already received FDA registration approval as the third after AstraZeneca vaccine from Astra Seneca (Thailand). Co., Ltd., which has been approved for registration on January 20, 2021 and the Corona Vac vaccine from Sinovac imported by the Government Pharmaceutical Organization Which was approved for registration on February 22, 2021
Outstanding news
There is also a vaccine from Bharat Biotech Technology, India. Imported by Biogen Tech Co., Ltd. In the process of continuous presentation or continuous presentation and for other vaccines, namely Modern vaccine. From the United States of America Russia’s Sputnik V vaccine and China’s Sino Farm vaccine have been in discussions with the FDA to prepare for the COVID-19 vaccine registration.
The FDA Secretary General added that Licensee to import drugs OR a licensee who is a private hospital or other private sector interested in applying for COVID-19 vaccine registration Able to submit documents to request an evaluation of quality, efficacy and FDA vaccine safety in comfort. Mobilizing experts from within and outside the FDA to participate in the consideration If full documents are submitted as required, evaluation and approval will take approximately 30 days, with FDA considering the quality and safety of vaccines in accordance with international standards. Give people safe access to vaccines.
Read more …
